Cite
Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.
MLA
Zhou, Run-Hong, et al. “Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 75, no. 2, June 2017, pp. 232–40. EBSCOhost, https://doi.org/10.1097/QAI.0000000000001361.
APA
Zhou, R.-H., Guo, L., Liu, J.-B., Liu, H., Hou, W., Ma, T.-C., Wang, X., Wu, J.-G., Ye, L., Ho, W.-Z., & Li, J.-L. (2017). Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection. Journal of Acquired Immune Deficiency Syndromes (1999), 75(2), 232–240. https://doi.org/10.1097/QAI.0000000000001361
Chicago
Zhou, Run-Hong, Le Guo, Jin-Biao Liu, Hang Liu, Wei Hou, Tong-Cui Ma, Xu Wang, et al. 2017. “Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.” Journal of Acquired Immune Deficiency Syndromes (1999) 75 (2): 232–40. doi:10.1097/QAI.0000000000001361.